Stent Grafts Market

Stent Grafts Market: Overview

Rising incidences of hypertension, expanding geriatric population, and growing awareness regarding aneurysm are prime factors that may propel the growth opportunities across the stent grafts market during the forecast period of 2021-2031. In addition, the growing importance of endovascular aneurysm repair is also projected to add value to the growth trajectory of the stent grafts market.

Stent grafts are tube-shaped devices prominently used during endovascular aneurysm repair processes. In this process, the stent grafts are implanted in the patients to prevent the damaged portion from rupturing. The benefits associated with using stent grafts may prove to be growth generators for the stent grafts market between 2021 and 2031. On the basis of product, the stent grafts market can be segmented into synthetic stent graft system and endovascular. Based on type, the stent grafts market can be categorized into bifurcated stent grafts and aorta-uni-iliac stent grafts.

The government bodies of numerous countries are investing extensively in strengthening their healthcare infrastructure to provide quality treatment to its citizens. This factor is estimated to have a positive impact on the growth of the stent grafts market. Furthermore, the expansion of clinical coverage across many regions and favorable reimbursement policies will add value to the growth trajectory of the stent grafts market.

The advent of the diagnostic imaging revolution along with the increasing popularity of computed tomography has resulted in the expansion of the practice of endograft sizing and placement. These factors bode well for the growth of the stent grafts market. However, the expensive nature of the stent grafts treatment and the complications related to stent grafts placement may dent the growth prospects of the stent grafts market to a considerable extent. Nevertheless, the players in the stent grafts market are working on improving these aspects to fill the void of market growth.

The report on stent grafts market by Transparency Market Research is a treasure of information required for the stakeholders. The report highlights the different aspects necessary for the growth of the stent grafts market such as regional dimensions, latest developments, threats, restraints, and the industrial insights. The information about these aspects is presented in a systematic and easy way to the stakeholders. The report also provides various graphs, pie charts, and diagrams to explain the growth trajectory of the stent grafts market in a detailed manner. In addition, the report also sheds light on the COVID-19 impact on the stent grafts market.

Stent Grafts Market: Industrial Insights

The stent grafts market has many players vying for expanding their consumer base. The players are involved in intense competition for increasing their prominence across the stent grafts market through launching new products and upgrade the existing ones. The players focus on research and development activities for adding value to their existing products. These activities ultimately contribute to the growth of the stent grafts market. Furthermore, the players participate in strategic collaborations to expand their presence in untapped regions, eventually increasing the growth rate of the stent grafts market.

Some key players into the stent grafts market are Lombard Medical, Inc., Lifetech Scientific (Shenzhen) Co. Ltd., Medtronic plc, Cook Medical Inc., Terumo Corporation, and B. Braun Melsungen AG.

Stent Grafts Market: Regional Dimensions

Among the regions associated with the stent grafts market, North America is prognosticated to dominate the geographical dimension of the stent grafts market. The growing popularity of minimally invasive surgeries and the expanding awareness about the importance of stent graft usage many prove to be growth accelerators for the stent grafts market in North America. In addition, Asia Pacific is also estimated to gain considerable growth for the stent grafts market. The rising investments in ramping up the healthcare infrastructure across many countries in Asia Pacific are expected to add value to the growth trajectory.